celiac disease

Researchers develop gluten-degrading enzymes to administer as drugs or incorporate into food and explore therapies that block downstream disease checkpoints.

A freshly discovered human cell type opens new research paths for understanding celiac disease, multiple sclerosis, and lupus. 

Re-engineering immune cells helps reverse immune dysregulation associated with autoimmune diseases.

Microbiome researchers seek to predict and prevent autoimmunity in infants.